These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9832936)

  • 1. Discriminative stimulus properties of nicotine at low doses: the effects of caffeine preload.
    Duka T; Tasker R; Russell K; Stephens DN
    Behav Pharmacol; 1998 May; 9(3):219-29. PubMed ID: 9832936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects.
    Perkins KA; Fonte C; Stolinski A; Blakesley-Ball R; Wilson AS
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):275-81. PubMed ID: 16366757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance.
    Gilbert DG; Dibb WD; Plath LC; Hiyane SG
    Psychophysiology; 2000 Sep; 37(5):583-95. PubMed ID: 11037035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine potentiates the discriminative-stimulus effects of nicotine in rats.
    Gasior M; Jaszyna M; Munzar P; Witkin JM; Goldberg SR
    Psychopharmacology (Berl); 2002 Aug; 162(4):385-95. PubMed ID: 12172692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine, nicotine and mecamylamine share stimulus properties in the preexposure conditioned taste aversion procedure.
    Kunin D; Bloch RT; Smith BR; Amit Z
    Psychopharmacology (Berl); 2001 Dec; 159(1):70-6. PubMed ID: 11797072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil discrimination by humans under a two-response and a novel-response procedure.
    Smith BJ; Bickel WK
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1257-68. PubMed ID: 10565850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
    Barrett RJ; Caul WF; Stadler JR; Smith RL
    Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended blockade of the discriminative stimulus effects of nicotine with low doses of ethanol.
    Korkosz A; Taracha E; Plaznik A; Wrobel E; Kostowski W; Bienkowski P
    Eur J Pharmacol; 2005 Apr; 512(2-3):165-72. PubMed ID: 15840401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports.
    Oliveto AH; Bickel WK; Hughes JR; Shea PJ; Higgins ST; Fenwick JW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):885-94. PubMed ID: 1602393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of alcohol pre-treatment on the discriminative stimulus, subjective, and relative reinforcing effects of nicotine.
    Perkins KA; Fonte C; Blakesley-Ball R; Stolinski A; Wilson AS
    Behav Pharmacol; 2005 Nov; 16(7):521-9. PubMed ID: 16170229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate.
    Bizarro L; Patel S; Murtagh C; Stolerman IP
    Behav Pharmacol; 2004 May; 15(3):195-206. PubMed ID: 15187577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognising nicotine: the neurobiological basis of nicotine discrimination.
    Smith JW; Stolerman IP
    Handb Exp Pharmacol; 2009; (192):295-333. PubMed ID: 19184654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment.
    Perkins KA; Fonte C; Meeker J; White W; Wilson A
    Behav Pharmacol; 2001 Feb; 12(1):35-44. PubMed ID: 11270510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.